Jammu, Apr 7 (PTI) The Indian Institute of Integrative Medicine (IIIM) Jammu signed an agreement on Monday with Kerala-based Pankajakasthuri India private limited for the pre-clinical validation of a poly-herbal formulation for bronchial asthma under the AYUSH framework.
The agreement for the sponsored research project was signed by Dr Zabeer Ahmed of CSIR-IIIM and Dr J Hareendran Nair of Pankajakasthuri in the presence of senior scientists and officials from both organisations, an IIIM spokesman said.
Also Read | Trump Tariffs: Global Stock Market Rout Continues.
"This collaboration focuses on the pre-clinical validation of a poly-herbal formulation designed to manage bronchial asthma, conducted under the AYUSH framework," he said.
As part of the project, CSIR-IIIM will carry out phytochemical standardization, in-vitro and in-vivo studies, and toxicity assessments of the herbal formulation, he said.
Dr Ahmed described the partnership as a "ground-breaking step" in scientifically validating AYUSH products, adding that the project is supported by the Ministry of AYUSH and the government of India.
He said the collaboration reflects a shared commitment to community well-being and sustainability.
Dr Nair said the association with CSIR-IIIM would strengthen public trust in their products. Pankajakasthuri's Executive Director Kishan Chand expressed satisfaction with the scientific discussions held with CSIR-IIIM, whose team will lead the research.
The partnership is seen as a significant move toward blending traditional knowledge with modern science to promote integrative medicine, the spokesman said.
Before the signing the agreement, CSIR-IIIM presented its achievements while Pankajakasthuri showcased a video on its corporate social responsibility (CSR) work.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)













Quickly


